• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ACG 临床指南:艰难梭菌感染的预防、诊断和治疗。

ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections.

机构信息

Division of Gastroenterology, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.

Division of Gastroenterology, Indiana University, Indianapolis, Indiana, USA.

出版信息

Am J Gastroenterol. 2021 Jun 1;116(6):1124-1147. doi: 10.14309/ajg.0000000000001278.

DOI:10.14309/ajg.0000000000001278
PMID:34003176
Abstract

Clostridioides difficile infection occurs when the bacterium produces toxin that causes diarrhea and inflammation of the colon. These guidelines indicate the preferred approach to the management of adults with C. difficile infection and represent the official practice recommendations of the American College of Gastroenterology. The scientific evidence for these guidelines was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation process. In instances where the evidence was not appropriate for Grading of Recommendations Assessment, Development, and Evaluation but there was consensus of significant clinical merit, key concept statements were developed using expert consensus. These guidelines are meant to be broadly applicable and should be viewed as the preferred, but not the only, approach to clinical scenarios.

摘要

艰难梭菌感染是由细菌产生毒素引起的,该毒素会导致腹泻和结肠炎症。这些指南指出了治疗艰难梭菌感染成人患者的首选方法,代表了美国胃肠病学会的官方实践建议。使用推荐评估、制定和评估(Grading of Recommendations Assessment, Development, and Evaluation,GRADE)过程对这些指南的科学证据进行了评估。在证据不适合推荐评估、制定和评估(Grading of Recommendations Assessment, Development, and Evaluation,GRADE)的情况下,但存在具有重要临床意义的共识时,使用专家共识制定了关键概念陈述。这些指南旨在广泛适用,应被视为临床情况的首选方法,但不是唯一方法。

相似文献

1
ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections.ACG 临床指南:艰难梭菌感染的预防、诊断和治疗。
Am J Gastroenterol. 2021 Jun 1;116(6):1124-1147. doi: 10.14309/ajg.0000000000001278.
2
Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.非培养方法诊断艰难梭菌感染时代粪便培养中产毒艰难梭菌生长的临床意义。
Microbiol Spectr. 2021 Oct 31;9(2):e0079921. doi: 10.1128/Spectrum.00799-21. Epub 2021 Oct 20.
3
Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.RBX2660 在 PUNCH CD3 中的疗效和安全性:一项 III 期、随机、双盲、安慰剂对照试验,采用贝叶斯主要分析预防复发性艰难梭菌感染。
Drugs. 2022 Oct;82(15):1527-1538. doi: 10.1007/s40265-022-01797-x. Epub 2022 Oct 26.
4
Diagnosis and Treatment of Clostridioides (Clostridium) difficile Infection in Adults in 2020.2020年成人艰难梭菌感染的诊断与治疗
JAMA. 2020 Apr 14;323(14):1403-1404. doi: 10.1001/jama.2019.3849.
5
Clostridioides difficile from intracardiac vegetation.心脏赘生物中的艰难梭菌。
Anaerobe. 2021 Jun;69:102350. doi: 10.1016/j.anaerobe.2021.102350. Epub 2021 Feb 18.
6
Recommendations and guidelines for the treatment of Clostridioides difficile infection in Taiwan.台湾地区艰难梭菌感染治疗的推荐意见和指南。
J Microbiol Immunol Infect. 2020 Apr;53(2):191-208. doi: 10.1016/j.jmii.2020.02.002. Epub 2020 Feb 14.
7
Recent development of small-molecular inhibitors against Clostridioides difficile infection.近期针对艰难梭菌感染的小分子抑制剂的研究进展。
Bioorg Chem. 2022 Aug;125:105843. doi: 10.1016/j.bioorg.2022.105843. Epub 2022 Apr 30.
8
A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea.艰难梭菌感染与抗生素相关性腹泻综述
Gastroenterol Clin North Am. 2021 Jun;50(2):323-340. doi: 10.1016/j.gtc.2021.02.010.
9
Acute-on-Chronic Liver Failure Clinical Guidelines.急性加重慢性肝衰竭临床指南。
Am J Gastroenterol. 2022 Feb 1;117(2):225-252. doi: 10.14309/ajg.0000000000001595.
10
Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.巴西南部艰难梭菌感染和复发的流行病学多中心研究。
Anaerobe. 2020 Aug;64:102238. doi: 10.1016/j.anaerobe.2020.102238. Epub 2020 Jul 24.

引用本文的文献

1
Fecal microbiota transplantation as a therapeutic modality for recurrent infection: reviewing efficacy, safety, mechanisms of action, and outcomes.粪便微生物群移植作为复发性感染的一种治疗方式:疗效、安全性、作用机制及结果综述
Ann Med Surg (Lond). 2025 Jul 25;87(9):5829-5850. doi: 10.1097/MS9.0000000000003649. eCollection 2025 Sep.
2
Optimizing short-term antibiotic treatment in patients with acute cholangitis: study protocol for an open-label randomized controlled trial (the BOLT-P3 trial).优化急性胆管炎患者的短期抗生素治疗:一项开放标签随机对照试验的研究方案(BOLT-P3试验)
Trials. 2025 Sep 1;26(1):324. doi: 10.1186/s13063-025-09077-1.
3
Infections: Epidemiological and Laboratory Data from the Internal Medicine Departments of a Tertiary Care Hospital in Athens, Greece, During the Past Decade.
感染:希腊雅典一家三级护理医院内科过去十年的流行病学和实验室数据。
Medicina (Kaunas). 2025 Aug 5;61(8):1416. doi: 10.3390/medicina61081416.
4
in Peripartum Women: Review of Outcomes and Treatment.围产期妇女:结局与治疗综述
Antibiotics (Basel). 2025 Aug 15;14(8):829. doi: 10.3390/antibiotics14080829.
5
What's New and What's Next in Fecal Microbiota Transplantation?粪便微生物群移植的新进展与未来方向?
Biologics. 2025 Aug 21;19:481-496. doi: 10.2147/BTT.S486372. eCollection 2025.
6
Baicalein ameliorates DSS-induced ulcerative colitis in mice by inhibiting ferroptosis and regulating gut microbiota.黄芩苷通过抑制铁死亡和调节肠道微生物群来改善小鼠实验性结肠炎。
Front Pharmacol. 2025 Jul 31;16:1564783. doi: 10.3389/fphar.2025.1564783. eCollection 2025.
7
Gut microbiota links to cognitive impairment in bipolar disorder via modulating synaptic plasticity.肠道微生物群通过调节突触可塑性与双相情感障碍中的认知障碍相关联。
BMC Med. 2025 Aug 12;23(1):470. doi: 10.1186/s12916-025-04313-6.
8
Trends and Efficacy in Clostridioides difficile Infection Management at a Polish Clinical Hospital.波兰一家临床医院艰难梭菌感染管理的趋势与疗效
Med Sci Monit. 2025 Aug 7;31:e948254. doi: 10.12659/MSM.948254.
9
Extraintestinal Manifestations of Infections: An Overview.感染的肠外表现:概述
Antibiotics (Basel). 2025 Jul 2;14(7):670. doi: 10.3390/antibiotics14070670.
10
Global Burden, Trends, and Inequalities of Infections from 1990 to 2021 and Projections to 2040: A Systematic Analysis.1990年至2021年感染的全球负担、趋势和不平等状况以及到2040年的预测:一项系统分析
Antibiotics (Basel). 2025 Jun 27;14(7):652. doi: 10.3390/antibiotics14070652.